More tools:Markets·Screener·Research·Chat

AtriCure, Inc. (ATRC) Financial Statements

AtriCure, Inc.
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001SD43V3
XNAS · usd
53.43▼ 0.30 (-0.56%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close53.73
Day's Range51.74 – 55.72
52-Week Range25.36 – 55.72
Volume1.9M
Avg Volume828.0K
Share Statistics
Shares Outstanding
Employees1,350
ExchangeXNAS
Listed2005-08-05
Share count as of July 22, 2026
Loading Income Statement…
Key questions about AtriCure, Inc. (ATRC)
What is AtriCure, Inc.'s Market Cap?
AtriCure, Inc.'s Market Cap is $2.7B, based on as-reported figures from SEC (XBRL) filings.
What is AtriCure, Inc.'s Enterprise Value?
AtriCure, Inc.'s Enterprise Value is $2.6B, based on as-reported figures from SEC (XBRL) filings.
What is AtriCure, Inc.'s Trailing P/E?
AtriCure, Inc.'s Trailing P/E is 257.6×, based on as-reported figures from SEC (XBRL) filings.
What is AtriCure, Inc.'s Price / Sales?
AtriCure, Inc.'s Price / Sales is 4.8×, based on as-reported figures from SEC (XBRL) filings.
What is AtriCure, Inc.'s EV / Revenue?
AtriCure, Inc.'s EV / Revenue is 4.6×, based on as-reported figures from SEC (XBRL) filings.
What is AtriCure, Inc.'s EV / EBITDA?
AtriCure, Inc.'s EV / EBITDA is 78.0×, based on as-reported figures from SEC (XBRL) filings.
What is AtriCure, Inc.'s Revenue (TTM)?
AtriCure, Inc.'s Revenue (TTM) is $569.6M, based on as-reported figures from SEC (XBRL) filings.
What is AtriCure, Inc.'s Net Income (TTM)?
AtriCure, Inc.'s Net Income (TTM) is $10.6M, based on as-reported figures from SEC (XBRL) filings.
What is AtriCure, Inc.'s EBITDA?
AtriCure, Inc.'s EBITDA is $33.7M, based on as-reported figures from SEC (XBRL) filings.
What is AtriCure, Inc.'s Diluted EPS (TTM)?
AtriCure, Inc.'s Diluted EPS (TTM) is 0.21, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth+12.8%+14.3%+13.1%+15.8%
Cost of revenue
Gross profit
% of revenue77.2%77.4%75.0%75.5%
Operating expenses:
Research and development expenses
Selling, general and administrative expenses
Total operating expenses
% of revenue70.9%77.0%73.2%75.3%
Income (loss) from operations
% of revenue6.3%0.4%1.8%0.2%
Other income (expense):
Interest expense
Interest income
Other income (expense)
Income (loss) before income tax expense
Income tax expense
Net income (loss)
% of revenue5.8%0.1%1.2%-0.2%
Basic net income (loss) per share (in usd per share)
Diluted net income (loss) per share (in usd per share)